Quantum量子訊息有限公司

Spatial Biology (Spatial Omics) Market

完整報告名稱與涵蓋範圍
Spatial Biology (Spatial Omics) Market Size, Share & Trends Analysis Report, By Product (Instruments and Imaging Platforms, Reagents, Panels and Consumables, Software, Image Analysis and Data Services), By Technology (Spatial Transcriptomics (Sequencing-Based and In Situ Imaging), Spatial Proteomics and Multiplex Immunofluorescence, Multi-Modal Spatial Platforms (Transcript, Protein and Morphology), Spatial Metabolomics and Mass Spectrometry Imaging), By Application (Oncology and Tumor Microenvironment Research, Immunology, Neuroscience and Developmental Biology, Drug Discovery and Translational Research, Clinical Pathology and Biomarker Development), By End User, By Region, and Segment Forecasts, 2026-2035

報告摘要

The spatial biology market covers instruments and imaging platforms, reagents and panels and software and data services that measure gene and protein expression and metabolite distribution within intact tissue sections, including sequencing-based and in situ spatial transcriptomics, spatial proteomics and multiplex immunofluorescence, multi-modal platforms that integrate transcript, protein and morphology and mass spectrometry imaging. Conventional immunohistochemistry, dissociated single-cell analysis addressed in a separate InsightAce study and digital pathology scanners are excluded. The field has grown quickly because tissue context determines biology in cancer, immunology and neuroscience, and because platforms now resolve thousands of transcripts and dozens of proteins at single-cell resolution across whole slides. Pharmaceutical companies are adopting spatial profiling to characterise tumor microenvironments, stratify trial cohorts and discover biomarkers, while consortia map human and disease atlases. Multi-modal instruments that combine RNA, protein and histology on one sample, higher throughput and lower cost per sample, automated image analysis and cloud data services are the principal development directions. Intellectual property litigation among platform companies, consolidation through acquisitions, reagent lock-in economics and the pathway to clinical assays shape the competitive landscape. North America and Europe dominate spending, with China, Japan and South Korea growing through domestic platforms and research investment. Competition involves spatial genomics leaders, proteomics and imaging platform companies, instrument groups that acquired spatial pioneers and software specialists. The InsightAce study supplies US$ forecasts for all product, technology, application and end user and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Spatial Biology (Spatial Omics) Market Snapshot Chapter 4. Global Spatial Biology (Spatial Omics) Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis 5.1. Product & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product: 5.2.1. Instruments and Imaging Platforms 5.2.2. Reagents, Panels and Consumables 5.2.3. Software, Image Analysis and Data Services Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis 6.1. Technology & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology: 6.2.1. Spatial Transcriptomics (Sequencing-Based and In Situ Imaging) 6.2.2. Spatial Proteomics and Multiplex Immunofluorescence 6.2.3. Multi-Modal Spatial Platforms (Transcript, Protein and Morphology) 6.2.4. Spatial Metabolomics and Mass Spectrometry Imaging Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis 7.1. Application & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application: 7.2.1. Oncology and Tumor Microenvironment Research 7.2.2. Immunology, Neuroscience and Developmental Biology 7.2.3. Drug Discovery and Translational Research 7.2.4. Clinical Pathology and Biomarker Development Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis 8.1. End User & Market Share, 2026 & 2035 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 8.2.1. Academic and Research Institutes 8.2.2. Pharmaceutical and Biotechnology Companies 8.2.3. Hospitals and Clinical Laboratories 8.2.4. Contract Research Organizations Chapter 9. Spatial Biology (Spatial Omics) Market: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. United States 9.1.2. Canada 9.2. Europe 9.2.1. Germany 9.2.2. United Kingdom 9.2.3. France 9.2.4. Italy 9.2.5. Spain 9.2.6. Rest of Europe 9.3. Asia Pacific 9.3.1. China 9.3.2. Japan 9.3.3. India 9.3.4. South Korea 9.3.5. Australia 9.3.6. Southeast Asia 9.3.7. Rest of Asia Pacific 9.4. Latin America 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 9.5. Middle East & Africa 9.5.1. GCC Countries 9.5.2. South Africa 9.5.3. Rest of Middle East & Africa Chapter 10. Competitive Landscape 10.1. Company Market Positioning Analysis 10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 11. Company Profiles 11.1. 10x Genomics, Inc. 11.2. Bruker Corporation (NanoString and Canopy) 11.3. Akoya Biosciences, Inc. 11.4. Vizgen, Inc. 11.5. Standard BioTools Inc. 11.6. Lunaphore Technologies (Bio-Techne Corporation) 11.7. Resolve Biosciences GmbH 11.8. Curio Bioscience 11.9. Ultivue, Inc. 11.10. Nanostring Legacy Platforms (Bruker) 11.11. Bio-Techne Corporation 11.12. Leica Microsystems (Danaher) 11.13. Roche Holding AG 11.14. Illumina, Inc. 11.15. Singular Genomics Systems, Inc.

圖表清單 List of Tables & Figures

Table 1. Global Spatial Biology (Spatial Omics) Market Revenue Forecast by Product, 2026-2035 (US$ Mn) Figure 1. Global Spatial Biology (Spatial Omics) Market Segmentation Overview Table 2. Global Spatial Biology (Spatial Omics) Market Revenue Forecast by Technology, 2026-2035 (US$ Mn) Figure 2. Global Spatial Biology (Spatial Omics) Market Share by Product, 2026 & 2035 Table 3. Global Spatial Biology (Spatial Omics) Market Revenue Forecast by Application, 2026-2035 (US$ Mn) Figure 3. Spatial Biology Technology Landscape by Modality, Plex and Resolution Table 4. Global Spatial Biology (Spatial Omics) Market Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 4. Global Spatial Biology (Spatial Omics) Market Share by Technology, 2026 & 2035 Table 5. North America Spatial Biology (Spatial Omics) Market Revenue by Country, 2026-2035 (US$ Mn) Figure 5. Pharmaceutical and Translational Adoption of Spatial Profiling, 2026-2035 Table 6. Europe Spatial Biology (Spatial Omics) Market Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Asia Pacific Spatial Biology (Spatial Omics) Growth Opportunity Analysis Table 7. Asia Pacific Spatial Biology (Spatial Omics) Market Revenue by Country, 2026-2035 (US$ Mn) Figure 7. Consolidation and Intellectual Property Dynamics Among Spatial Platform Companies, 2022-2026 Table 8. Latin America Spatial Biology (Spatial Omics) Market Revenue by Country, 2026-2035 (US$ Mn) Figure 8. Competitive Positioning of Key Spatial Biology (Spatial Omics) Market Participants Table 9. Middle East & Africa Spatial Biology (Spatial Omics) Market Revenue by Country, 2026-2035 (US$ Mn)

提及公司

10x Genomics, Inc.Bruker Corporation (NanoString and Canopy)Akoya Biosciences, Inc.Vizgen, Inc.Standard BioTools Inc.Lunaphore Technologies (Bio-Techne Corporation)Resolve Biosciences GmbHCurio BioscienceUltivue, Inc.Nanostring Legacy Platforms (Bruker)Bio-Techne CorporationLeica Microsystems (Danaher)Roche Holding AGIllumina, Inc.Singular Genomics Systems, Inc.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們